Compound details
Dihydromorelloflavone
| Compound ID | CDAMM01490 |
|---|---|
| Common name | Dihydromorelloflavone | IUPAC name | 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one |
| Molecular formula | C30H22O11 |
| Retention time | 13.27 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 559.131 | Theoretical mz | 559.123 |
| Error | 14.53 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1797 |
| Inchi key | IMIXFUXOSFSXPC-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1C2=C(O)C=C(O)C(=C2OC(C3=CC=C(O)C(O)=C3)C1)C4C(=O)C=5C(O)=CC(O)=CC5OC4C6=CC=C(O)C=C6 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| P06870 | KLK1 | Kallikrein 1 | T40000 | SwissTargetPrediction and SEA |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SwissTargetPrediction and SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P49763 | PGF | Placenta growth factor | T70792 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P52209 | PGD | 6-phosphogluconate dehydrogenase | T76497 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T70792 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P49763 | PGF |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T76497 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P52209 | PGD |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |